158 related articles for article (PubMed ID: 35129052)
21. Menopausal hormones and risk of ovarian cancer.
Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
[TBL] [Abstract][Full Text] [Related]
22. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
[TBL] [Abstract][Full Text] [Related]
23. Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study.
Rosenberg LU; Granath F; Dickman PW; Einarsdóttir K; Wedrén S; Persson I; Hall P
Breast Cancer Res; 2008; 10(5):R78. PubMed ID: 18803850
[TBL] [Abstract][Full Text] [Related]
24. Hormonal therapy and risk of breast cancer in mexican women.
Amadou A; Fabre A; Torres-Mejía G; Ortega-Olvera C; Angeles-Llerenas A; McKenzie F; Biessy C; Hainaut P; Romieu I
PLoS One; 2013; 8(11):e79695. PubMed ID: 24260282
[TBL] [Abstract][Full Text] [Related]
25. Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies.
Carrasquilla GD; Frumento P; Berglund A; Borgfeldt C; Bottai M; Chiavenna C; Eliasson M; Engström G; Hallmans G; Jansson JH; Magnusson PK; Nilsson PM; Pedersen NL; Wolk A; Leander K
PLoS Med; 2017 Nov; 14(11):e1002445. PubMed ID: 29149179
[TBL] [Abstract][Full Text] [Related]
26. Cause-specific mortality in women receiving hormone replacement therapy.
Schairer C; Adami HO; Hoover R; Persson I
Epidemiology; 1997 Jan; 8(1):59-65. PubMed ID: 9116097
[TBL] [Abstract][Full Text] [Related]
27. The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women.
Seed M; Sands RH; McLaren M; Kirk G; Darko D
Fam Pract; 2000 Dec; 17(6):497-507. PubMed ID: 11120722
[TBL] [Abstract][Full Text] [Related]
28. Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases.
Vinogradova Y; Dening T; Hippisley-Cox J; Taylor L; Moore M; Coupland C
BMJ; 2021 Sep; 374():n2182. PubMed ID: 34588168
[TBL] [Abstract][Full Text] [Related]
29. Menopausal hormone therapy use and long-term all-cause and cause-specific mortality in the Long Island Breast Cancer Study Project.
Wang T; Bradshaw PT; Moorman PG; Nyante SJ; Nichols HB; Shantakumar S; Parada H; Khankari NK; Terry MB; Teitelbaum SL; Neugut AI; Gammon MD
Int J Cancer; 2020 Dec; 147(12):3404-3415. PubMed ID: 32588422
[TBL] [Abstract][Full Text] [Related]
30. Oestrogens and the heart.
Rosano GM; Panina G
Therapie; 1999; 54(3):381-5. PubMed ID: 10500455
[TBL] [Abstract][Full Text] [Related]
31. Sex hormones and the cardiovascular system: effects on arterial function in women.
Teede HJ
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):672-6. PubMed ID: 17581228
[TBL] [Abstract][Full Text] [Related]
32. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
[TBL] [Abstract][Full Text] [Related]
33. Effect of menopausal hormone therapy on COVID-19 severe outcomes in women - A population-based study of the US National COVID Cohort Collaborative (N3C) data.
Yoshida Y; Chu S; Zu Y; Fox S; Mauvais-Jarvis F;
Maturitas; 2023 Apr; 170():39-41. PubMed ID: 36773498
[TBL] [Abstract][Full Text] [Related]
34. Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France.
Cordina-Duverger E; Truong T; Anger A; Sanchez M; Arveux P; Kerbrat P; Guénel P
PLoS One; 2013; 8(11):e78016. PubMed ID: 24223752
[TBL] [Abstract][Full Text] [Related]
35. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women.
McCrohon JA; Adams MR; McCredie RJ; Robinson J; Pike A; Abbey M; Keech AC; Celermajer DS
Clin Endocrinol (Oxf); 1996 Oct; 45(4):435-41. PubMed ID: 8959082
[TBL] [Abstract][Full Text] [Related]
36. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
[TBL] [Abstract][Full Text] [Related]
37. Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study.
Daugherty SE; Lacey JV; Pfeiffer RM; Park Y; Hoover RN; Silverman DT
Int J Cancer; 2013 Jul; 133(2):462-72. PubMed ID: 23319449
[TBL] [Abstract][Full Text] [Related]
38. Menopause and post-menopause.
Prelevic GM; Jacobs HS
Baillieres Clin Endocrinol Metab; 1997 Jul; 11(2):311-40. PubMed ID: 9403125
[TBL] [Abstract][Full Text] [Related]
39. The influence of menopausal hormone therapy on tumour characteristics and survival in endometrial cancer patients.
Orgéas CC; Hall P; Wedrén S; Dickman PW; Czene K
Eur J Cancer; 2009 Nov; 45(17):3064-73. PubMed ID: 19493676
[TBL] [Abstract][Full Text] [Related]
40. Menopausal hormones and breast cancer in a biracial population.
Moorman PG; Kuwabara H; Millikan RC; Newman B
Am J Public Health; 2000 Jun; 90(6):966-71. PubMed ID: 10846517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
